For example, in patients with hematological malignancies who failed to produce anti-SARS-CoV antibodies, the innate systemic response was primarily characterized by IL-8 and MIP-1α, with a significant reduction in the IFN-γ, IL-15, and IP-10/CXCL10 response (30). This evidence concerns the gene CXCL10 and hematologic disorder.